BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional ...

Researchers from Eclypsium find vulnerability in the way iSeq 100 boots up The bug allows threat actors to establish persistence, brick the device, or tamper with the results A patch has since ...

Eclypsium security researchers have uncovered UEFI vulnerabilities in the Illumina iSeq 100 DNA sequencer, but the broader issue involves the device development process at large. In highlighting ...

On Tuesday, researchers from firmware security firm Eclypsium called out one of them: the Illumina iSeq 100, a DNA sequencer that's a staple at 23andMe and thousands of other gene-sequencing ...